Table 1. Structures of tyrosine kinase inhibitors used in this study.
| Drug Code | Structure | Class of Inhibitor | Most active kinase |
|---|---|---|---|
| 47F |  |
Imatinib-Analog | Aurora A kinase |
| 23D |  |
Staurosporine | Broad spectrum kinase inhibitor |
| 32C |  |
No syk activity | CDC7, promiscuous |
| 32D |  |
No syk activity | MAP2K1, promiscuous |
| 32A3 |  |
No syk activity | CDK9, promiscuous |
| 32E |  |
Syk inhibitor IV | Syk |
| 47H |  |
Syk inhibitor R406 | Syk |
| 47A3 |  |
Syk inhibitor IV analog | Syk, PI-3 kinase |
| 26D |  |
Syk inhibitor IV analog | Syk, PI-3 kinase |
| 23B3 | Proprietary structure | No syk activity | CDC7, promiscuous |